Metropolis Healthcare Limited has informed the Exchange about meeting with investors scheduled on April 17, 2026
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare has informed the stock exchanges about an investor meeting with Nuvama Institutional Equities scheduled for April 17, 2026, starting at 12:00 noon IST. The meeting will be held at the company's Global Reference Laboratory in Kurla and will begin with a lab tour followed by a group interaction. The company has clarified that the discussions will be limited to publicly available information and no unpublished price sensitive information (UPSI) will be shared. The intimation is filed under SEBI Listing Regulations as a standard disclosure.
This is a routine compliance filing with no direct material impact on shareholders. The lab tour and group interaction may help institutional investors gain better understanding of the company's diagnostic operations, but no new business information is expected to be shared.